Camel Snus MRTP Application, Slides of Epidemiology

Frost. Frost Large. Mellow. Mint. Robust. Winterchill. Camel Snus Extracts Are. Less Cytotoxic than Cigarette Smoke.

Typology: Slides

2022/2023

Uploaded on 03/01/2023

wualter
wualter 🇺🇸

4.8

(96)

287 documents

1 / 171

Toggle sidebar

This page cannot be seen from the preview

Don't miss anything!

bg1
Camel Snus MRTP Application
September 13-14, 2018
Tobacco Products Scientific Advisory Committee
CC-1
pf3
pf4
pf5
pf8
pf9
pfa
pfd
pfe
pff
pf12
pf13
pf14
pf15
pf16
pf17
pf18
pf19
pf1a
pf1b
pf1c
pf1d
pf1e
pf1f
pf20
pf21
pf22
pf23
pf24
pf25
pf26
pf27
pf28
pf29
pf2a
pf2b
pf2c
pf2d
pf2e
pf2f
pf30
pf31
pf32
pf33
pf34
pf35
pf36
pf37
pf38
pf39
pf3a
pf3b
pf3c
pf3d
pf3e
pf3f
pf40
pf41
pf42
pf43
pf44
pf45
pf46
pf47
pf48
pf49
pf4a
pf4b
pf4c
pf4d
pf4e
pf4f
pf50
pf51
pf52
pf53
pf54
pf55
pf56
pf57
pf58
pf59
pf5a
pf5b
pf5c
pf5d
pf5e
pf5f
pf60
pf61
pf62
pf63
pf64

Partial preview of the text

Download Camel Snus MRTP Application and more Slides Epidemiology in PDF only on Docsity!

  • Camel Snus MRTP Application Tobacco Products Scientific Advisory Committee September 13-14,

Introduction and Overview Michael Ogden, PhD Senior Vice President, Scientific & Regulatory AffairsRAI Services Company

An Important Consideration •

There is no one-size-fits-all approach to dramatically reducethe harm from smoking

  • Different types of reduced-risk products appeal to different people

    Clearing the proposed MRTP advertising for Camel Snusis a scientifically sound step to reduce tobacco risk

Presentation Topics •

Camel Snus history, product development and design

Proposed modified risk advertising - Scientific evidence that individual health risk is reducedwhen smokers switch to Camel Snus - Consumer studies showing the proposed advertising willpromote beneficial behavioral changes in smokers - Statistical modeling indicating the population as a wholewill benefit from the resulting risk reductions

The Tobacco and Nicotine Product Risk Continuum

Consumers needaccurate informationabout the relativerisks of products toencourage them tomigrate to lessharmful products Product Switching Cigarettes Smokeless Tobacco Nicotine Replacement Therapies RelativeRisk forChronicDisease

Camel Snus Product Design •

Camel Snus is a spitless, pouched,smokeless tobacco product

Designed to have risk-reductioncharacteristics of Swedish snus - Made with low-toxicant tobaccos– Has same basic formulation– Flavors adapted for American palate using common smokeless tobaccoand food ingredients Each tin contains 15 pouches Finely milled tobacco,humectants and flavorings Fleece pouch

Camel Snus Production Process and Styles

Frost Mint Mellow Frost Large Winterchill Robust 600 mg 1000 mg

Production Process

  • Low toxicant, finely milled tobaccos– Mixed with water, salt and heat-treated– Buffered with pH-stabilizing solution, further heat-treated– Humectants and flavors added

Camel Snus MRTP Messaging Topline •

Only seeking authorization for the specific modified risk messagesand layouts submitted to the FDA

Presents adult smokers with accurate, easily understoodcomparative risk information - No change to current product label or government smokeless tobacco warnings - Subject to post-market surveillance

Overview of Print Advertisement

Advertising Execution 2

Camel Snus MRTP Messages – 1

st

Panel

Advertising Execution 2 Maintains government warning Note cigarette crushed by snus tin Introduces opportunity for adult smokers to reduce risk

Camel Snus MRTP Messages – 3

rd

Panel

Advertising Execution 2 Balancing information Additional benefits of switching Key modified risk statement (variations among executions)

Camel Snus MRTP Messages – 3

rd

Panel

Advertising Execution 2

Variations in Key Modified Risk Statement – 3 rd Panel Execution 1 Execution 2 Execution 3

Camel Snus MRTP Messages – 3

rd

Panel

Advertising Execution 2